Naproxen
NDC 69238-1730, Naproxen, suspension, from Amneal Pharmaceuticals NY LLC.
- Product NDC
- 69238-1730
- Status
- Listed
- Labeler
- Amneal Pharmaceuticals NY LLC
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA212705
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69238-1730 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NAPROXEN25 mg/mL
Pharmacologic classes
Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69238-1730-2 | 69238173002 | 473 mL in 1 BOTTLE (69238-1730-2) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/985aedc1-8b3c-4cb4-af13-7203a2b57ab7NADAC price for package 69238173002
GET /v1/drugs/nadac/69238173002
Use it
Look up 69238-1730 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69238-1730 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69238-1730. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.